ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
January 19, 2024 07:00 ET
|
ProQR Therapeutics N.V.
Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human primates (NHPs) and miceFunctional effect demonstrated in mice in vivo via...
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
December 01, 2023 07:00 ET
|
AC Immune SA
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO Outstanding scientist and entrepreneur Dr. Madiha Derouazi appointed as new CSORetiring CSO Dr....
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
February 24, 2023 09:00 ET
|
GT Biopharma, Inc.
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...
Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
November 08, 2022 07:30 ET
|
Zai Lab Limited
SHANGHAI and CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today...
Xequel Bio Expands Leadership Team with Appointments of Dr. Michael J. Brubaker as Chief Scientific Officer and Tony C. Tipton as Chief Operating Officer
July 26, 2022 09:00 ET
|
Xequel Bio, Inc.
CHARLESTON, S.C. and FORT WORTH, Texas, July 26, 2022 (GLOBE NEWSWIRE) -- Xequel Bio, Inc., a clinical stage biopharmaceutical company developing dermatologic and ophthalmic therapeutics utilizing...
Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer
June 30, 2022 03:30 ET
|
Element Materials Technology
LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief...
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
April 11, 2022 09:25 ET
|
22nd Century Group, Inc
Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...
Freeline Appoints Henning R. Stennicke, PhD, as Chief Scientific Officer to Lead Research and Discovery
February 03, 2022 07:00 ET
|
Freeline Therapeutics
LONDON, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative...
Qualis Innovations Inc. Announces the Appointment of Dr. Robert Bilkovski as Chief Scientific Officer of mPathix Health Inc.
July 14, 2021 13:46 ET
|
Qualis Innovations, Inc.
Chadds Ford, PA, July 14, 2021 (GLOBE NEWSWIRE) -- mPathix Health Inc., a wholly owned subsidiary of Qualis Innovations Inc., (OTC: QLIS), a pain solutions company focused on developing and...
Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer
May 03, 2021 08:05 ET
|
Aeterna Zentaris Inc
– Over 20 years of industry experience in translating research into clinical development in a wide range of therapeutic areas of endocrinology and oncology CHARLESTON, S.C., May 03, 2021 (GLOBE...